Royal Bank of Canada’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-98
| Closed | – | – | 6617 |
|
|
2024
Q4 | $0 | Sell |
98
-2
| -2% | – | ﹤0.01% | 6572 |
|
|
2024
Q3 | $0 | Sell |
100
-161
| -62% | – | ﹤0.01% | 6771 |
|
|
2024
Q2 | $0 | Buy |
261
+105
| +67% | – | ﹤0.01% | 6926 |
|
|
2024
Q1 | $0 | Sell |
156
-109
| -41% | – | ﹤0.01% | 6860 |
|
|
2023
Q4 | $0 | Buy |
265
+167
| +170% | – | ﹤0.01% | 6852 |
|
|
2023
Q3 | $0 | Hold |
98
| – | – | ﹤0.01% | 6876 |
|
|
2023
Q2 | $0 | Hold |
98
| – | – | ﹤0.01% | 7021 |
|
|
2023
Q1 | $0 | Hold |
98
| – | – | ﹤0.01% | 6864 |
|
|
2022
Q4 | $0 | Sell |
98
-53
| -35% | – | ﹤0.01% | 7046 |
|
|
2022
Q3 | $0 | Buy |
151
+53
| +54% | – | ﹤0.01% | 7194 |
|
|
2022
Q2 | $0 | Hold |
98
| – | – | ﹤0.01% | 7073 |
|
|
2022
Q1 | $0 | Hold |
98
| – | – | ﹤0.01% | 7352 |
|
|
2021
Q4 | $0 | Sell |
98
-564
| -85% | – | ﹤0.01% | 7216 |
|
|
2021
Q3 | $2K | Buy |
+662
| New | +$2K | ﹤0.01% | 6825 |
|